Delving into the Latest Updates on YHD-001 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

Immune System DiseasesInfectious DiseasesRespiratory Diseases

Active Indication-

Inactive Indication

Acute BronchitisAsthmaBronchitis, Chronic

Originator Organization

Yuhan Corp.

Active Organization-

Inactive Organization

Yuhan Corp.

License Organization-

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

Login to view timeline

The main objective is to evaluate the safety/tolerability and efficacy of YHD001 compared to singulair or placebo in patients (n=96) with partially controlled asthma.
The study will conduct with 4 comparative groups orally treated with YHD001 dose level 1(t.i.d.), YHD001 dose level 2(t.i.d.), singulair 10mg(q.d.) or Placebo for 8 weeks.

Start Date01 Nov 2011

Sponsor / Collaborator

Yuhan Corp.

NCT01420445

/ CompletedPhase 2

Randomized, Double-blind, Placebo/Active-controlled, Multi-center, Phase 3 Clinical Trial to Investigate the Safety/Tolerability and Efficacy of YHD001 After Oral Administration in Patients With Acute or Chronic Bronchitis

The study will conduct with 4 comparative groups orally treated with YHD001 dose level 1(t.i.d.), YHD001 dose level 2(t.i.d.), pelargonium sidoides extract 9mL(t.i.d.) or Placebo for 7 days.
The treatments will be assigned randomly to patients (n=116) with acute or chronic bronchitis.

Start Date01 Sep 2011

Sponsor / Collaborator

Yuhan Corp.

100 Clinical Results associated with YHD-001

Login to view more data

100 Translational Medicine associated with YHD-001

Login to view more data

100 Patents (Medical) associated with YHD-001

Login to view more data

100 Deals associated with YHD-001

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Asthma	Phase 2	South Korea	Yuhan Corp.	01 Nov 2011
Acute Bronchitis	Phase 2	South Korea	Yuhan Corp.	01 Sep 2011
Bronchitis, Chronic	Phase 2	South Korea	Yuhan Corp.	01 Sep 2011